CEVR analyzes the value of strategies to improve health and health care.

About Us

Recent Publications

Health Affairs Scholar
The timeliness of health plan drug coverage policy changes to FDA label revisions
View publication
February 13, 2026
Health Affairs Scholar
FDA approvals of specialty drugs, 2000-2024
View publication
February 7, 2026
JAMA Network Open
Drug Prices, Rebates, and Health Plan Coverage Restrictions
View publication
February 6, 2026
JMCP
Use of Clinical Outcome Assessments in Specialty Drug Coverage Policies
View publication
February 4, 2026
AJMC
Communication of Launch Prices by Drug Companies, 2022-2024
View publication
December 15, 2025
Health Affairs Forefront
Do Medicare’s IPAY 2027 Negotiated Drug Prices Reflect Value For Money?
View publication
December 11, 2025
Journal of Neuromuscular Disease
US Health Plan Coverage of Neuromuscular Disease Therapies: An Assessment of Policy Availability and Restrictions
View publication
December 9, 2025
Health Affairs Forefront
The ‘Pharm-To-Table’ Movement For Prescription Drugs: Promising Or Performative?
View publication
December 5, 2025

The CEVR Team

Our team of experienced, dedicated researchers is led by health economists Peter Neumann and Josh Cohen. Together we produce cutting-edge health care cost-effectiveness research.

Meet the CEVR Team

Our Databases

Our comprehensive databases provide the information individuals and organizations need to analyze the benefits, risks, and costs of strategies to improve health and health care.